sorafenib has been researched along with tripalmitin in 1 studies
Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (tripalmitin) | Trials (tripalmitin) | Recent Studies (post-2010) (tripalmitin) |
---|---|---|---|---|---|
6,520 | 730 | 5,251 | 189 | 4 | 72 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amore, E; Augello, G; Bondì, ML; Botto, C; Cervello, M; Craparo, EF; Emma, MR | 1 |
1 other study(ies) available for sorafenib and tripalmitin
Article | Year |
---|---|
Lipid nanocarriers containing sorafenib inhibit colonies formation in human hepatocarcinoma cells.
Topics: Antineoplastic Agents; Caprylates; Cell Survival; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Hemolysis; Hep G2 Cells; Humans; Lipids; Microscopy, Electron, Scanning; Nanoparticles; Niacinamide; Particle Size; Phenylurea Compounds; Sorafenib; Triglycerides | 2015 |